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1. Introduction 
Anti-Mϋllerian hormone (AMH) is a glycoprotein that belongs to the transforming growth 
factor-β (TGF-β) superfamily [1]. AMH, also known as a Mϋllerian inhibiting substance 
(MIS), has been mainly studied for its regulatory role in male sex differentiation and induces 
regression of the Mϋllerian ducts, the anlagen of the female reproductive tract [2]. AMH 
expression can first be observed in granulosa cells of primary follicles, and its expression is 
strongest in preantral and small antral follicles (<4mm). AMH expression disappears in 
follicles as their size increases and is almost completely lost in follicles larger than 8mm, 
where only very weak expression remains, restricted to the granulosa cells of the cumulus 
[3]. This expression pattern suggests that, also in women, AMH may play a role in the initial 
recruitment and in the selection of the dominant follicles.  To assess an individual’s ovarian 
reserve, early follicular phase serum levels of FSH, inhibin B and estoradiol (E2) have been 
measured. Inhibin B and E2 are produced rarely by antral follicles in response to FSH, and 
contribute to the classical feedback loop of the pituitary-gondola axis to suppress FSH 
secretion. With the decline of the follicle pool, serum levels of inhibin B and E2 decrease and 
subsequently serum FSH levels rise [4].The likely explanations are that AMH and FSH are 
highly correlated [5]. In women undergoing treatment for infertility, ovarian aging is 
characterized by decreased ovarian responsiveness to exogenous gonadotrophin and poor 
pregnancy outcome. On the one hand, correct identification of poor responders by 
assessment of the ovarian reserve before entering an IVF program is important. On the other 
hand, assessment of the ovarian reserve may also benefit patients that would generally be 
excluded from an IVF program because of advanced age. 
Automatic follicle analysis has the potential to remove any observer bias and to reduce the 
time needed for measurements, but it must be both valid and reliable [6]. This is particularly 
true within the field of reproductive medicine, with ultrasound being used on a daily basis 
to follow the ovarian response to gonadotropins in a process known as follicle tracking [7]. 
Two-dimensional (2D) measurements are then made and their mean is taken as the true 
follicular diameter, which is relatively straightforward but follicle tracking becomes more 
difficult as the number of follicles increases [6]. Therefore, recently, three-dimensional (3D) 
ultrasound with Sono AVC (Automatic Volume Calculation) has been used to quantify 
hypoechoic regions within a three-dimensional dataset and provide automatic estimation of 
their absolute dimensions, mean diameter and volume. Each individual volume is given a 
specific color and the automated measurements of the mean diameter (relaxed sphere 
diameter), maximum dimensions (x, y, z diameters) and volume are displayed using these 
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colors in descending order of size. Sono AVC provides measurements of follicular diameter 
that are more accurate than manual measures and has the potential to improve the clinical 
workflow because the time taken for the measurements is significantly shorter [8]. The 
quantification of power Doppler assesses blood flow within the ovary and quantitative 3D-
power Doppler angiography has been used to demonstrate the blood flow around the 
follicles within the ovary. These tools are new methods to analyze the effect of ovary 
stimulation. The power Doppler data within the 3D dataset can be quantified to generate 
volumetric measures of blood flow within the dataset as whole or within specific volumes 
within the dataset. Various software programmes are available to facilitate this, but the one 
used most frequently is the histogram facility in 4D View (GE Medical System, Zipf, 
Austria), which generates three indices of vascularity: the vascularization index (VI), the 
flow index (FI), and the vascularization flow index (VFI). These vascular indices are 
generated through specific algorithms based on signal intensity and the relative proportion 
of color voxels (3D pixels) within the defined volume [9]. This study was designed to assess 
the ability of the combination of AMH and 3D-power Doppler histogram techniques, 
including the Virtual Organ Computer-aided (VOCAL) software, to generate volume 
measurements of the ovary. These new combinational ultrasound techniques were used to 
investigate patient undergoing IVF treatment. 
2. Materials and methods 
This was a prospective cohort study of 28 patients undergoing controlled ovarian 
hyperstimulation. All of the patients met the following inclusion criteria: (1) Both ovaries 
were present with no morphological abnormalities, (2) Regular menstrual cycle lengths 
ranging between 25 and 34 days, (3) No current or past diseases affecting the ovaries or 
gonadotrophin or sex steroid section, clearance, or excretion, (4) No clinical signs of 
hyperandrogenism, (5) Body Mass Indexes ranging from 18 to 25kg/m2, (6) No current 
hormone therapy, (7) Adequate visualization of both ovaries in transvaginal ultrasound 
scans. Informed consent was obtained from all patients and this investigation was approved 
by our internal Institutional Review Board. 
2.1 IVF treatment 
Patients were treated with a time-release GnRH agonist from day 2 of menses (Day2). On 
Day 3, complete pituitary desensitization was confirmed by the detection of low serum 
levels of E2 and gonadotrophins. Patients also underwent a conventional ultrasound 
examination to exclude ovarian cysts and to verify that the endometrium was <5mm. 
Recombinant FSH therapy (recombinant Follitropin beta) or HMG was then initiated at a 
dose of 150 IU/day, while daily Gn-RH agonist administration was continued until the day 
of administration of hCG at 10,000 IU dose.  
2.2 AMH  
Blood was sampled between days 1 to 16 of menses (Day 1 to 16) from women undergoing 
IVF treatment. Follicular fluid was obtained from the follicles at Day 14. Blood and follicle 
fluid were centrifuged at 3,000 bpm/min for 10 minutes, and then stored at -20C until 
immunoassay. Serum AMH (S-AMH) levels were assessed using enzyme immunoassay 
AMH/MIS-EIA (IMMUNOTECH A BECKMAN COULTER COMPANY). Recombinant 
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human AMH was used as a calibration standard to generate a standard curve (conversion 
factor to pmol/l=ng/ml×7.14). 
2.3 3D ultrasound methods. 
Ultrasound image sampling was performed on 28 patients undergoing IVF treatment from 
Day 1 to 16. All assessments were performed using a ultrasound machine and a four-
dimensional 9MHz trans-vaginal probe. This provides visualization of the three orthogonal 
planes so that the central point of the follicle within the right ovary (RO) and the left ovary 
(LO) were consistent for all three images.  
2.4 Sono AVC 
The Sono AVC was activated when it had been correctly positioned and magnified. The 
setting of growth and separation within the software was maintained at a default value of 
mid for all follicle measurements. The Sono AVC identifies the follicle by giving it a specific 
color (Figure 1a) and provides automated measurements of the mean diameter (relaxed 
sphere diameter), maximum dimensions (x y z diameters) and volume (Figure 1b). 
2.5 Virtual Organ Computer-aided (VOCAL) and 3D power Doppler volume histogram 
3D power Doppler volume histogram was generated based on the VOCAL method. The 
stimulated ovary was used to measure each index of blood flow in vasculature and vessels per 
gray scale ratio in the ovary, resulting in the Vacularization Index (VI), Flow Index (FI) and 
Vascularization Flow Index (VFI). These indexes display on the volume histogram (Figure 2). 
2.6 Statistical analysis 
Student’s t-test and Fisher’s exact test were conducted using Stat View 5.0 (Abacus 
Concepts, Inc. Berkeley CA, 1996). Principal component analysis (PCA) and Receiver 
operating characteristic (ROC) curves were calculated using SPSS 17.0 (SPSS Japan Inc).  
3. Results 
This study population consisted of 28 patients. The age range was 25 to 44 years (under 35 
years: n=6, 35-39 years: n=8, over 40 years: n=14), and the mean age was 36.74±5.88 years. 
Blood samples were obtained from each patient and 3D ultrasound examination was 
performed at Day 10.04±5.8 (range: 1 to16). The number of oocytes aspirated was 5.6±3.6 
(range; 0 to 16), and the number of embryos generated was 3.3±2.8 (range: 0 to 11). 
3.1 AMH  
The mean S-AMH level was 0.47±0.125 ng/ml, and the level in the patient under 35 years of 
age undergoing IVF treatment (0.570±0.216 ng/ml) was significantly higher than that in 
patient over 40 years of age (0.377±.070 ng/ml; p=0.0003) (Figure 3a), and the mean S-AMH 
level which was 0.469± 0.181 ng/ml in 35 to 39 years of age. The relationship between the 
mean S-AMH levels and age of women undergoing IVF treatment was significant (r=0.459, 
p=0.0004. 95%CI: -0.23 to 0.07) (Figure 3b). These results show that S-AMH levels reduced 
with the increasing age of women undergoing IVF.  
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(a) 
 
(b) 
1a The Sono AVC identifies the follicle by giving it a specific color 
1b many follicles automatically were measured that displayed report on monitor 
Fig. 1. Automatic volume calculation (Sono AVC) was used to automatically calculate the 
volume of the follicle. 
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Three-dimensional power Doppler histogram was used to determine the vascular and blood flow, 
Vascularization indices (VI; vascularization index, FI; flow idex, VFI; vascularization flow index) from 
computer algorithms. 
Fig. 2. Three-dimensional power Doppler image around follicle in ovary. 
3.2 3D ultrasound methods 
3.2.1 Sono AVC 
The mean number of follicles was 5.61±3.28 from the right ovary (range: 0 to 13) vs. 
5.46±4.56 from the left ovary (range: 0 to 19). The mean volume of the right follicle was 
0.6999±0.613 cm3 (range: 0.0 to 2.846; cm3), and the mean volume of left follicle was 
0.675±0.845 cm3 (range: 0.0 to 3.220; cm3).  
3.2.2 3D-power Doppler Volume histogram  
The mean FI of the RO and LO were 34.39±9.897 and 29.88±19.66%, respectively. The mean 
VI of the RO was significant higher LO (RO vs., LO; 7.61±1.121 vs., 3.30±0.679, p=0.013), and 
the mean VFI of the RO was high compare with LO (RO vs., LO; 2.37±0.337 vs., 0.776±0.844, 
p=0.024). The mean FI was no difference of index between RO and LO. 0.924) and decreased 
the S-AMH (oocyte 0.583, embryo 0.647).  
3.2.3 The ROC curve 
In the embryo, the cut-off value for the S-AMH was 0.2855 ng/ml (AUC; 0.56, sensitivity, 
83.3%. specificity, 92.9%; 95% CI, 0.268 to 0.851) (Figure 4a) and the optimum cut-off point 
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(a) 
 
(b) 
3a Under 35 years of age of patient (0.47±0.125) was significantly higher than over 40 years of patient 
(0.377±.070) (p=00003). 35 to39 years of age was 0.570±0.216 ng/ml. 
*p<0.05compared to three different group by Fisher’s exact test 
3b Serum-AMH level corrected for age of patient undergoing in vitro fertilization treatment 
r=0.459, p=0.0004.295%CI: -0.23 to 0.07 by linear regression. 
Fig. 3. Serum-AMH level (ng/ml) relation with age of patient undergoing in vitro 
fertilization treatment 
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for the number of embryo was an age of 32.5 years (AUC; Sensitivity; 100%, Specificity; 
52.6%, 95% CI 0.542 to 0.892) (Figure 4b).  
  
                                     (a)                                                                           (b) 
4a ROC curve that Serum-AMH of cut -off value which took embryo relation with lime of age was 
0.2855ng/ml (AUC 0.56. sensitivity, 83.3%. specificity, 92.6 %; 95% CI, 0.268-0.851) (Figure 5c). 
4b ROC curve that embryos were taken for the lime of age was 32.5 years (AUC; 0.62, Sensitivity; 100%, 
Specificity; 52.6%, 95% CI 0.542 to 0.892) (Figure 5d).  
Fig. 4. The Receiver-operating characteristic (ROC) curve indicate cut-off value. 
4. Discussion 
4.1 AMH 
In this study, we investigated whether AMH and measurements could be useful markers of 
successful generation of embryos from patients undergoing IVF treatment, and examined 
the relationship with the embryo using 3D ultrasonography. We further tested the 
diagnostic performance of AMH and the age limit of patients undergoing IVF treatment on 
the number of embryos obtained, by ROC curves. These data led to the conclusion that 
AMH, Sono AVC and 3D-power Doppler histogram could provide the best available clinical 
markers of responsiveness to the ovarian stimulation. Our results indicate that AMH is 
suitable as an effectiveness factor, such as the generation of embryos with IVF treatment, by 
principal component analysis. We also found that the S-AMH cut-off value was 0.2855 
ng/ml (AUC: 0.56. sensitivity, 83.3%. specificity, 92.9%; 95% CI, 0.268 to 0.851 ) in all cases 
and the optimum age cut-off was 32.5 years (AUC: 0.643. sensitivity, 100%. Specificity, 
52.6%; 95% CI, 0.453 to 0.833). In 2007, Zappacosta et al. reported the Bland-Altman plot 
analysis (AxSYM Abbott) shows that the immunonephelometric method has a slight 
positive bias with both HPLC (mean: 1.03µmol/L, 95% confidence interval:0.28-1.79µmol/L) 
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and AxSYM methods (mean: 0.45µmol/L, 95% confidence interval:-0.03-0.94µmol/L ) AMH 
is a significantly correlated with ovarian response in IVF cycles. Indeed, linear regression 
analysis shows a significant association between AMH and the number of ovocytes collected 
[11]. AMH levels in women with correct ovarian response range from 0.63 ng/ml [12] to 
0.67ng/ml [13]. Scott et al. demonstrated that a single measurement of circulating AMH can 
be used to individualize treatment strategies for IVF, potentially resulting in reduced clinical 
risk, along with optimized treatment burden, and clinical pregnancy rates, with the 
application of the Gn-RH antagonist protocol appearing to be advantageous for patients at 
the anticipated extremes of ovarian response [14]. In 2009, Singer et al. reported that the use 
of FSH and AMH in combination might improve the evaluation of ovarian reserve. 
However, it remains to be determined which of these two ovarian function parameters is 
superior in assessing ovarian reserve with a single test and which test, or combination of 
tests is most appropriate [5]. In our study, we did not demonstrate to determine FSH and 
AMH in combination, and the relationship between S-AMH and successful pregnancy, we 
think that the reasons which are the first, it is most important determine AMH level 
compare with FSH level, because FSH levels are effected of FSH stimulate ovarian function 
undergoing IVF treatment, and the second, likely pregnancy has many factors, including 
hormones, the immune-cytokine network and the developing syncytium of cells in the 
endometrium of the uterus. Therefore, the aim of our study was clearly distinct from these 
studies, as we assessed the combination of AMH and 3D ultrasound methods that 
automatically measure follicles and blood flow in ovaries during IVF treatment. Particularly, 
we indicated that the S-AMH relation with the age during IVF treatment from the limit of 
the S-AMH was 0.2855ng/ml and the number of embryos (≥2 ) with an optimum cut-off age 
of 32.5 years. We believe that these cut-off values are predictive of a poor response 
undergoing IVF treatment. Finally, it is nasally to analyze S-AMH levels and to consider age 
undergoing IVF treatment. Gnoth et al reported that cut-off that AMH is a predictor of 
ovarian response and is suitable for screening. A calculated cut-off level≤1.26ng/ml AMH 
alone detected poor responders (≤4 oocytes) with a sensitivity of 97%, and there was a 98% 
correct prediction of normal response to IVF treatment if levels were above this threshold. 
With levels of 0.5ng/ml, a correct prediction of very poor response (≤2 oocytes) was possible 
in 88% of cases. The Gnoth group report that AMH levels ≥0.5ng/ml did not correlate 
significantly with clinical pregnancy rates. Measurement of AMH supports clinical 
decisions, but alone it is not a suitable predictor of IVF success [15]. However, they did not 
report that a relationship between the cut-off level of serum AMH and the age limit of 
patient undergoing on the number of embryos obtained. Their level of AMH ≤1.26ng/ml (≤4 
oocytes) was higher than our S-AMH level of 0.284ng/ml (oocytes=5; sensitivity, 83.3%. 
specificity, 92.9%; 95% CI, 0.268 to 0.851). The Gnoth group used a high dose of IVF 
compared with our dose of IVF treatment, and designated two groups of women; those who 
were under 35 years and from 35 to 39 years. We suggest that these differences of result 
occur in between the Gnoth group and our study that it might be due to the doses used 
during ovarian stimulation and design of group. Other hand, in this study, we showed that 
the mean FF-AMH level was 0.639±0.290 ng/ml, and there was no relationship between the 
FF-AMH level and age of women undergoing IVF treatment (r=0.102, p=0.007, 95%CI; -.024 
to 0.025). Lee et al. reported that FF-AMH is a marker that reflects ovarian reserve and 
response to controlled ovarian hyperstimulation. But, FF-AMH levels did not correlate 
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significantly with age, gonadotrophin dose, the number of follicles on the hCG day, and the 
number of oocytes retrieved [16]. It is interesting that the findings of the FF-AMH in Lee’s 
study were different from our own; for example, the sample sizes were different between 
these investigations (our study vs. Lee’s study; n=28 vs. n=87 patients). Second, the dosing 
protocols of IVF were different between these studies; Lee’s study had two protocols, 
including the Gn-RH-a long protocol group (n=43,FF-AMH=1.8±0.4ng/ml), in which Gn-
RH-a triptorelin (Decapeptyl, 0.1mg/d; Ferring, Malmo, Sweden) was started in the mid-
luteal phase of the previous cycle. After pituitary down-regulation, the triptorelin dose was 
reduced to 0.05mg/dl, and recombinant FSH (Gonal-F; Serono, Genova, Switzerland) was 
added when two or more follicles reached a diameter of 17 mm, and the other protocol was 
the GnRH agonist multiple-dose flexible protocol (n=44, FF AMH=1.3±0.3), recombinant 
FSH (Gonal-F, Serono) was started on the 2nd and 3rd menstrual-cycle day without 
pretreatment with oral contraceptive [16]. However, our results possibility demonstrated 
that S-AMH levels exhibits a significant relationship between age of patient undergoing IVF 
and the successful developed embryos, compared with FF-AMH levels, in the form a 
protocol that implemented the GnRH agonist- a short protocol in this study. 
4.2 3D ultrasound  
The vascular indices determined by analysis of the 3D-power Doppler histogram represent 
the proportion of vascularized tissue (or vascularization index: VI), the amplitude of blood 
movement in the sampled tissue ( or flow index: FI) and the proportion of vascularized and 
blood movement in the volumetric sample (or vascularization flow index: VFI) [17]. In a 
recent study, the VI, which was defined as the percentage of the power Doppler signal 
within a defined volume of interest, was suggested to be representative of the number of 
vessels in, or the vascularity of, the region of interest [18]. It is that characteristic of FI that is 
comprised of blood flow and attenuation factors, for example, the signal intensity is a direct 
consequence of the erythrocyte concentration [19], tissue motion [20], and machine settings 
[21]. Indeed, Dubiel et al. found in their flow phantom study that a four-fold increase in 
flow velocity only resulted in a 10% increase in FI. This, together with our data suggests 
that, despite the often-reported assumption, FI does not represent flow [22]. The 3D-power 
Doppler vascular indices provide a description of the amount and/or the movement of 
blood in a volumetric image (tissue). Therefore, vascularization and/or flow in the entire 
organ may not be represented by an individual tissue sample, or sampled tissues with 
different volumes will most likely present different vascular indices [20]. Jones et al. found 
using in vitro dual perfusion of human placental lobules, a predictable relationship between 
flow rates and the vascular indices, VI and VFI, however the FI was a less reliable predictor 
of flow; thus, it should be interpreted with caution [23]. Our results agree with the report by 
Jones et al. Furthermore, we explain that the results of FI are related to tissue motion and the 
specific techniques of each investigator. In the anatomy of the ovary, the ovarian artery, a 
branch of the aorta, courses along the infundibulopelvic ligament and the mesovarium 
border of the ovary, where it anastomoses with the ovarian branch of the uterine artery. 
Approximately 10 arterial branches arise from this arcade and penetrate the ovarian hilus, 
becoming markedly coiled and branched as they course through the medulla. These helicine 
arteries have longitudinal ridges of intimal smooth muscle. At the corticomedullary 
junction, the medullary arteries and arterioles form a plexus, from which smaller, straight 
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cortical arterioles arise and penetrate the cortex in a radial fashion, perpendicular to the 
ovarian surface. These cortical arterioles branch and anastomose several times, forming sets 
of interconnected vascular arcades. These arcades give rise to capillaries, which form dense 
networks within the theca layers of the ovarian follicles [24]. In conclusion, we automatically 
and quickly detected the number of follicles using Sono AVC, and vascularization around 
the follicles in the ovary by analysis of the 3D-power Doppler histograms. These results 
were expected to provide an indicator of ovarian function during IVF treatment. The S-
AMH was related to the age of women undergoing COH, further investigations of the level 
of S-AMH which was necessary to confirm the cut-off level, and the VI might be parameter 
of vascularized formation around follicle in ovary using 3D-power Doppler histogram. 
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The book is coined to provide a professional insight into the different trends of immunoassay and related
techniques. It encompasses 22 chapters which are grouped into two sections. The first section consists of
articles dealing with emerging uni-and-multiplex immunolabelled methods employed in the various areas of
research. The second section includes review articles which introduce the researchers to some
immunolabelled techniques which are of vital significance such as the use of the conjugates of the
Staphylococcus aureus protein "A" and the Streptococcus Spps. protein "G" in immunolabelled assay systems,
the use of bead-based assays and an overview on the laboratory assay systems. The book provides
technological innovations that are expected to provide an efficient channel for developments in
immunolabelled and related techniques. It is also most useful for researchers and post-graduate students, in
all fields, where immunolabelled techniques are applicable.
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